Effect of valproic acid through regulation of NMDA receptor-ERK signaling in sleep deprivation rats

Journal of Molecular Neuroscience

Volumn 47, Issue 3, 2012, Pages 554-558

  Park, Hae Jeong ^a   Kang, Won Sub ^a   Paik, Jong Woo ^a   Kim, Jong Woo ^a  

^a Kyung Hee University Hospital   (South Korea)

Author keywords

Extracellular signal regulated protein kinase; N methyl D aspartic acid receptor; Sleep deprivation; Valproic acid

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 1; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2A; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2B; PROTEIN BCL 2; VALPROIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; FRONTAL CORTEX; HIPPOCAMPUS; MALE; MANIA; NERVE CELL PLASTICITY; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; SLEEP DEPRIVATION;

ANIMALS; ANTIMANIC AGENTS; FRONTAL LOBE; HIPPOCAMPUS; MALE; MAP KINASE SIGNALING SYSTEM; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE; SLEEP DEPRIVATION; VALPROIC ACID;

ANIMALIA; RATTUS;

EID: 84863878698     PISSN: 08958696     EISSN: 15591166     Source Type: Journal    
DOI: 10.1007/s12031-011-9673-5     Document Type: Article

References (23)

1. Bazinet RP, Weis MT, Rapoport SI, Rosenberger TA (2006) Valproic acid selectively inhibits conversion of arachidonic acid to arachidonoyl-CoA by brain microsomal long-chain fatty acyl- CoA synthetases: relevance to bipolar disorder. Psychopharmacology (Berl) 184:122-129 (Pubitemid 43005765)
2. Bowden CL, Karren NU (2006) Anticonvulsants in bipolar disorder. Aust NZ J Psychiatry 40:386-393
3. Chen G, Manji HK (2006) The extracellular signal-regulated kinase pathway: an emerging promising target for mood stabilizers. Curr Opin Psychiatry 19:313-323 (Pubitemid 44309491)
4. Coenen AM, van Luijtelaar EL (1985) Stress induced by three procedures of deprivation of paradoxical sleep. Physiol Behav 35:501-504 (Pubitemid 16237697)
5. Du J, Gray NA, Falke C, Yuan P, Szabo S, Manji HK (2003) Structurally dissimilar antimanic agents modulate synaptic plasticity by regulating AMPA glutamate receptor subunit GluR1 synaptic expression. Ann NY Acad Sci 1003:378-380 (Pubitemid 38083076)
6. Einat H, Yuan P, Gould TD et al (2003) The role of the extracellular signal-regulated kinase signaling pathway in mood modulation. J Neurosci 23:7311-7316 (Pubitemid 36999520)
7. Fratta W, Collu M, Martellotta MC, Pichiri M, Muntoni F, Gessa GL (1987) Stress-induced insomnia: opioid-dopamine interactions. Eur J Pharmacol 3:437-440 (Pubitemid 18063964)
8. Frau R, Orrù M, Puligheddu M et al (2008) Sleep deprivation disrupts prepulse inhibition of the startle reflex: reversal by antipsychotic drugs. Int J Neuropsychopharmacol 11:947-955
9. Frey BN, Valvassori SS, Réus GZ et al (2006) Effects of lithium and valproate on amphetamine-induced oxidative stress generation in an animal model of mania. J Psychiatry Neurosci 31:326-332 (Pubitemid 44497429)
10. Gessa GL, Pani L, FrattaW SG (1995a) Depression and mania: from neurobiology to treatment. Raven, New York
11. Gessa GL, Pani L, Fadda P, FrattaW(1995b) Sleep deprivation in the rat: an animal model of mania. Eur Neuropsychopharmacol 5:S89-S93
12. Kanai H, Sawa A, Chen RW, Leeds P, Chuang DM (2004) Valproic acid inhibits histone deacetylase activity and suppresses excitotoxicity-induced GAPDH nuclear accumulation and apoptotic death in neurons. Pharmacogenomics J 4:336-344 (Pubitemid 39341573)
13. Kim MJ, Dunah AW, Wang YT, Sheng M (2005) Differential roles of NR2A- and NR2B-containing NMDA receptors in Ras-ERK signaling and AMPA receptor trafficking. Neuron 46:745-760 (Pubitemid 40733130)
14. Kim E, Grover LM, Bertolotti D, Green TL (2010) Growth hormone rescues hippocampal synaptic function after sleep deprivation. Am J Physiol Regul Integr Comp Physiol 298:1588-1596
15. Lan MJ, McLoughlin GA, Griffin JL et al (2009) Metabonomic analysis identifies molecular changes associated with the pathophysiology and drug treatment of bipolar disorder. Mol Psychiatry 14:269-279
16. Martin ED, Pozo MA (2004) Valproate reduced excitatory postsynaptic currents in hippocampal CA1 pyramidal neurons. Neuropharmacology 46:555-561 (Pubitemid 38224441)
17. McDermott CM, Hardy MN, Bazan NG, Magee JC (2006) Sleep deprivation-induced alterations in excitatory synaptic transmission in the CA1 region of the rat hippocampus. J Physiol 570:553-565
18. Nasrallah HA, Ketter TA, Kalali AH (2006) Carbamazepine and valproate for the treatment of bipolar disorder: a review of the literature. J Affect Disord 95:69-78 (Pubitemid 46110784)
19. Rao JS, Harry GJ, Rapoport SI, Kim HW(2010) Increased excitotoxicity and neuroinflammatory markers in postmortem frontal cortex from bipolar disorder patients. Mol Psychiatry 15:384-392
20. Sanacora G, Zarate CA, Krystal JH, Manji HK (2008) Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders. Nat Rev Drug Discov 7:426-437 (Pubitemid 351619114)
21. Sweatt JD (2004) Mitogen-activated protein kinases in synaptic plasticity and memory. Curr Opin Neurobiol 14:311-317
22. Yuan P, Zhou R, Wang Y et al (2010) Altered levels of extracellular signal-regulated kinase signaling proteins in postmortem frontal cortex of individuals with mood disorders and schizophrenia. J Affect Disord 124:164-169
23. Zeise ML, Kasparow S, Zieglgansberger W (1991) Valproate suppresses N-methyl-D-aspartate-evoked, transient depolarizations in the rat neocortex in vitro. Brain Res 544:345-348